Compare BTG & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTG | TFX |
|---|---|---|
| Founded | 2006 | 1943 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 5.8B |
| IPO Year | 2007 | 1994 |
| Metric | BTG | TFX |
|---|---|---|
| Price | $5.11 | $124.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $6.45 | ★ $154.73 |
| AVG Volume (30 Days) | ★ 17.7M | 741.6K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.60% | 1.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.08 |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $21.66 | $13.82 |
| Revenue Next Year | $18.24 | $4.32 |
| P/E Ratio | ★ $34.75 | $59.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.57 | $100.18 |
| 52 Week High | $6.29 | $145.00 |
| Indicator | BTG | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 39.33 |
| Support Level | $5.08 | $119.23 |
| Resistance Level | $5.68 | $128.06 |
| Average True Range (ATR) | 0.18 | 3.37 |
| MACD | -0.05 | 0.23 |
| Stochastic Oscillator | 22.78 | 57.13 |
B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.